ALT Prostate Cancer Foundation 2026 PCF TACTICAL Awards Targeting Mechanisms of Lethal Prostate Cancer REQUEST FOR LETTERS OF INTENT IMPORTANT: Applying for a PCF TACTICAL Award (Therapy ACceleration To Intercept CAncer Lethality) involves a 2-stage process. PCF requires a Letter of Intent (LOI), followed by full application submission upon our invitation. The Prostate Cancer Foundation (PCF) is pleased to announce a Request for LOIs for PCF TACTICAL Awards from qualified teams of investigators from academic and community institutions that will directly contribute to improved outcomes for patients with prostate cancer with lethal potential. These awards will be funded depending on the level of innovation and transformative potential in applications received. PCF seeks high-risk, currently unfunded projects from academic and community research institutions around the world. TACTICAL Awards provide $5 - $10 Million U.S.D. per award over 3–5 years.
ALT Prostate Cancer Foundation 2026 Young Investigator Awards REQUEST FOR APPLICATIONS The Prostate Cancer Foundation (www.pcf.org) champions investment in human capital to fast-forward solutions for prostate cancer with the ultimate goal of ending death and suffering from metastatic prostate cancer. We continue to focus significant efforts on developing gifted cohorts of young prostate cancer researchers. Since 2007, PCF has awarded 469 PCF Young Investigator Awards in 16 countries, making it one of the most prodigious, productive, competitive and prestigious early career awards in cancer research. We are pleased to announce a new round of funding for PCF Young Investigators. We especially encourage young investigators working on prostate cancer health disparities to apply. The mission of PCF is to fund research addressing unmet medical needs in the diagnosis and treatment of potentially lethal prostate cancer.
ALT Prostate Cancer Foundation 2026 PCF Challenge Awards For Prostate Cancer with Lethal Potential REQUEST FOR APPLICATIONS The Prostate Cancer Foundation (PCF) is pleased to announce a Request for Applications for PCF Challenge Awards for Team Science investigations of prostate cancer with lethal potential. These awards will be funded depending on the level of innovation in applications received. PCF seeks high-risk, currently unfunded projects from academic and community research institutions around the world. PCF Challenge Awards: • Should be composed of at least 3 investigators capable of providing unique scientific expertise to the solution of this significant problem in prostate cancer research. • May be assembled from one institution, or several institutions. • Must embed at least one young investigator as an integral contributor to the team. To qualify as a young investigator, this team member must have a doctoral-level degree and be within six years of completion of their terminal
ALT Screenshot of article published in "The Prostate" REVIEW ARTICLE Deciphering Resistance: Beyond the Androgen Paradigm; Report From the 2025 Coffey-Holden Prostate Cancer Academy Meeting Tanya Stoyanova, Saul J. Priceman, Ashley E. Ross, Phuoc T. Tran, Rana R. McKay, Kenneth J. Pienta, Howard R. Soule, Andrea K. Miyahira First published: 07 December 2025 https://doi.org/10.1002/pros.70102 Tanya Stoyanova, Saul J. Priceman, Ashley E, Ross, Phuoc T. Tran, and Rana R. McKay contributed equally to this manuscript. ABSTRACT Introduction The 12th Annual 2025 Coffey—Holden Prostate Cancer Academy (CHPCA) Meeting, “Deciphering Resistance: Beyond the Androgen Paradigm,” was held at the University of California, Los Angeles (UCLA), Luskin Conference Center, in Los Angeles, CA, from June 19 to 22, 2025.
ALT Prostate Cancer Grant: Deadline December 1, 2025! This grant was created in collaboration with the SNMMI Mars Shot Research Fund and Prostate Cancer Foundation for innovative research addressing unmet medical needs in the diagnosis and treatment of prostate cancer. This is a three-year grant and will provide $75,000 for three (3) years with travel expense to the PCF YI Meeting included. For full details and to submit your application, apply through the official grant portal.
ALT The 31st Annual Prostate Cancer Foundation Scientific Retreat Report Andrea K. Miyahira, Howard R. Soule First published: 27 July 2025 https://doi.org/10.1002/pros.70015 ABSTRACT Background The 31st Annual Prostate Cancer Foundation (PCF) Scientific Retreat took place in Carlsbad, CA on October 24–26, 2024. Methods The Annual PCF Scientific Retreat is the foremost international conference focused on emerging and cutting-edge basic, translational, and clinical prostate cancer research, as well as research from related disciplines with strong potential to advance prostate cancer understanding and improve patient outcomes.
ALT Prostate Cancer Foundation 2025 PCF TACTICAL Awards Targeting Mechanisms of Lethal Prostate Cancer REQUEST FOR LETTERS OF INTENT / FULL APPLICATIONS IMPORTANT: Applying for a PCF TACTICAL Award (Therapy ACceleration To Intercept CAncer Lethality) involves a 3-stage process. PCF requires a Letter of Intent (LOI), followed by full application submission upon our invitation. Following peer review, top applicants will undergo a Zoom-based interview. The Prostate Cancer Foundation (PCF) is pleased to announce a Request for LOIs for PCF TACTICAL Awards from qualified teams of academic scientists that will specifically address the development of 21st Century therapies for lethal forms of prostate cancer. These awards will be funded depending on the level of innovation in applications received. PCF seeks high-risk, currently unfunded projects from academic institutions around the world. TACTICAL Awards provide $5 - $10 Million U.S.D. per award over 3-5 years. • Support large-scale...
ALT Prostate Cancer Foundation 2025 PCF Challenge Awards For Metastatic, Lethal Prostate Cancer REQUEST FOR APPLICATIONS The Prostate Cancer Foundation (PCF) is pleased to announce a Request for Team Science Applications for PCF Challenge Awards for investigations of metastatic, lethal prostate cancer. These awards will be funded depending on the level of innovation in applications received. PCF seeks high-risk, currently unfunded projects from academic institutions around the world. PCF Challenge Awards: • Composed of a team of at least three (3) investigators from non-profit academic research centers, including one young investigator (see PCF Challenge Award Team requirements below). • Support large-scale research projects concerning metastatic, lethal prostate cancer over a duration of two years. • Provide up to a total of $1 million per team. • Cover only direct research costs and travel to the Annual PCF Scientific Retreat. • Clinical trial direct costs are not allowed; however...
